Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
296.23
+5.06 (1.74%)
Jul 3, 2025, 1:00 PM - Market closed
Cencora Employees
Cencora had 46,000 employees as of September 30, 2023. The number of employees increased by 2,000 or 4.55% compared to the previous year.
Employees
46,000
Change (1Y)
2,000
Growth (1Y)
4.55%
Revenue / Employee
$6,744,178
Profits / Employee
$36,811
Market Cap
57.42B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
Sep 30, 2020 | 22,000 | 0 | - |
Sep 30, 2019 | 22,000 | 1,000 | 4.76% |
Sep 30, 2018 | 21,000 | 1,000 | 5.00% |
Sep 30, 2017 | 20,000 | 1,000 | 5.26% |
Sep 30, 2016 | 19,000 | 1,500 | 8.57% |
Sep 30, 2015 | 17,500 | 3,500 | 25.00% |
Sep 30, 2014 | 14,000 | 1,000 | 7.69% |
Sep 30, 2013 | 13,000 | -1,500 | -10.34% |
Sep 30, 2012 | 14,500 | 4,200 | 40.78% |
Sep 30, 2011 | 10,300 | 300 | 3.00% |
Sep 30, 2010 | 10,000 | -300 | -2.91% |
Sep 30, 2009 | 10,300 | -600 | -5.50% |
Sep 30, 2008 | 10,900 | -400 | -3.54% |
Sep 30, 2007 | 11,300 | -3,400 | -23.13% |
Sep 30, 2006 | 14,700 | 1,300 | 9.70% |
Sep 30, 2005 | 13,400 | -700 | -4.96% |
Sep 30, 2004 | 14,100 | -700 | -4.73% |
Sep 30, 2003 | 14,800 | 1,100 | 8.03% |
Sep 30, 2002 | 13,700 | 0 | - |
Sep 30, 2001 | 13,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
COR News
- 2 days ago - Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release - Business Wire
- 5 weeks ago - Cencora Elects Lori J. Ryerkerk to Its Board of Directors - Business Wire
- 7 weeks ago - Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs - Seeking Alpha
- 2 months ago - Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings - Benzinga
- 2 months ago - Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cencora raises annual profit forecast on strong demand for specialty drugs - Reuters
- 2 months ago - Cencora Reports Fiscal 2025 Second Quarter Results - Business Wire
- 3 months ago - 3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock - Barrons